Imagine a digital companion for young people who have beaten cancer, helping them navigate life after treatment. It acts like a personalized roadmap that tells them which check-ups they need and how to handle side effects in their own language. Instead of guessing their health needs, it gives them and their families a clear, easy-to-use guide for a better daily life.
Healthcare systems are overburdened and cannot provide the intensive, personalized long-term follow-up care required by cancer survivors. This leads to unmet psychosocial needs and unequal access to care across different European regions.
A suite of interoperable e-health tools including MyCaree-QuoL, LOG-After, and SurPass, featuring co-created articles, videos, and translated MOOCs.
If you are a health-tech app developer dealing with fragmented patient data — this project developed MyCaree-QuoL and LOG-After that provide a seamless user journey for survivors. This allows for the creation of specialized modules for long-term follow-up care.
If you are a private oncology clinic dealing with an overburdened healthcare system — this project developed e-health tools that enable patients to self-manage their well-being. This reduces the resource demand on medical staff while maintaining care quality.
If you are a health insurance provider dealing with high long-term morbidity costs — this project developed tools for preventive behaviors like nutrition and physical activity. This helps reduce the risk of late health effects and excess mortality for the 35,000 annual CAYAC cases.
Based on available project data, specific pricing or cost details are not provided, although the objective mentions making tools affordable.
Yes, the project involves 16 countries and focuses on culturally adapted information in local languages to ensure equity across Europe.
Based on available project data, the licensing terms are not specified, but the project involves adapting existing interoperable tools.
The project explored interoperability between MyCaree-QuoL, LOG-After, and SurPass to ensure a seamless journey without over-medicalizing the experience.
The project period runs from 2024-01-01 to 2027-12-31.
The consortium is highly diverse with 32 partners across 16 countries, showing strong European reach. While dominated by research (12) and university (7) entities, it includes 2 SMEs and 2 industrial partners, indicating a bridge between academic validation and market application. The inclusion of 11 'Other' organizations suggests strong ties to patient associations and health institutes.
Contact GCS HOPITAUX UNIVERSITAIRES GRAND OUEST in France
Contact us to explore licensing opportunities for the MyCaree-QuoL toolset.
